AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence | Machine Learning | Machine Perception Cyclica | Decentralize Drug Discovery

Consumer, Biotechnology, Drug Development, Drug Discovery, Medical Toronto, ON, Canada

Artificial Intelligence | Machine Learning | Machine Perception

Cyclica | Decentralize Drug Discovery

Biotechnology, Drug Development, Drug Discovery, Medical

Toronto, ON, Canada

Cyclica is a biotechnology company that leverages AI and computational biophysics to decentralize drug discovery.

The company approaches polypharmacology with a structure-based, AI-augmented in silico discovery platform, centred on Ligand Design and Ligand Express. Powered by MatchMaker™, a proprietary deep learning proteome screening technology, and POEM™, an innovative supervised learning technology for predicting molecular properties, Cyclica’s platform is suited to the design of novel, drug-like chemical matter by simultaneously prioritizing compounds based on their on- and off-target polypharmacological profiles as well as their developmental properties. With a team that has deep roots in the industry, a platform, and an innovative decentralized partnership model, Cyclica is creating medicines with precision for unmet patient needs.

Jason Mitakidis and Naheed Kurji founded the biotech company in Toronto, Ontario in 2013.